Skip to content
DraconiticResearch
Search Sources API
190,839 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY-NC-ND 4.0JACS Au

Co-engineering DNAzymes and Phagemid Systems for Efficient and Scalable Production of Functional Single-Stranded DNA Nanostructures

6 affiliations
  1. 1East China University of Science and Technology , , ,
  2. 2Shanghai Institute of Applied Physics, Chinese Academy of Sciences , , ,
  3. 3Fudan University , , ,
  4. 4Shanghai Jiao Tong University , , ,
  5. 5Shanghai University , , ,
  6. 6Jiangxi Normal University , , ,

Abstract

DNA nanostructures have been widely explored for diverse applications, yet their scalable and cost-efficient production remains a major limitation. Phagemid-based biosynthesis of single-stranded DNA (ssDNA) provides a promising approach, but its efficiency is constrained by limited deoxyribozyme (DNAzyme) performance and suboptimal system design. Here, we develop an optimized bioproduction platform for ssDNA nanostructures by simultaneously engineering DNAzymes and phagemid-based production systems. Sequence-guided DNAzyme design identifies determinants for catalytic efficiency and pH adaptability, enabling highly efficient and robust in cis cleavage. The optimized DNAzymes achieve 100% self-cleavage within 30 min and expand the operational pH range from a narrow window around 7.2 to 6.6–7.8, thus enabling more reliable production of target ssDNA for structural folding. By combining optimization of phagemid constructs and helper phage/plasmid combinations, the resulting platform supports the biotechnological production of different nanostructures, including square and aptamer-functionalized triangle assemblies. With the p3024 phagemid and VCSM13 helper phage, production of functionalized triangular ssDNA nanostructures was successfully scaled to a 5 L bioreactor, yielding 151.0 mg/L phagemid ssDNA. Doxorubicin-loaded, aptamer AS1411-functionalized triangular nanostructures (DOX@DN-AS1411) enabled targeted and rapid intracellular drug delivery in breast cancer cells. This work establishes a scalable platform to produce programmable DNA nanostructures, facilitating their translation toward biomedical and nanomanufacturing applications.

Related

  1. Janus Nanostructures Enabled by Confined Interfacial Engineering for Enhanced Electromagnetic Response
    Limeng Song, Cheng Song, Feiyue Hu +15
    Advanced SciencePeer-reviewedCC BY 4.0Full text3 citedMaterials & polymersPMC
  2. A Review of High-Entropy Alloys (HEAs): Phase Stability, Nanostructures, Mechanical Behavior, and Future Engineering Applications
    Benedict Raphael Soesanto, Lee Zhi Szen, Jason Chua Teng Sern +3
    NanomaterialsPeer-reviewedCC BY 4.0Materials & polymersCrossref
  3. Engineering Cu/Ni-O Nanostructures via Bimetallic MOF Conversion for High-Performance Asymmetric Supercapacitors
    Surya Veerendra Prabhakar Vattikuti, Nunna Guru Prakash, Jaesool Shim
    BatteriesPeer-reviewedCC BY 4.0Electrochemistry & energyCrossref
  4. Engineering MoOₓ-based catalysts and reaction conditions to balance deoxygenation and hydrogenation in glycerol conversion for stable propylene production
    Mohamed El Doukkali, Meryem Bahlouri, Svetlana Heyte +2
    Chemical Engineering JournalPeer-reviewedLicence not statedCatalysisHAL
  5. Phase Engineering of WO3 Nanoparticles Towards Efficient Photochromic Nanocomposites
    Nicola Caggiano, Carlo Nazareno Dibenedetto, Elisabetta Fanizza +6
    Molecules (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral chemistryEurope PMC
BibTeX
@article{hu2026coengineering,
  title = {{Co-engineering DNAzymes and Phagemid Systems for Efficient and Scalable Production of Functional Single-Stranded DNA Nanostructures}},
  author = {Jinyi Hu and Wanqing Ding and Ning Jiang and Yujie Wang and Junjun Hou and Hongzhou Gu and Linjie Guo and Lihua Wang and Jiang Li and Jiaofang Huang and Jiangchao Qian},
  journal = {JACS Au},
  year = {2026},
  month = nov,
  doi = {10.1021/jacsau.6c01405},
  url = {https://pubs.acs.org/jaaucr/article/doi/10.1021/jacsau.6c01405/5462646/Co-engineering-DNAzymes-and-Phagemid-Systems-for},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Co-engineering DNAzymes and Phagemid Systems for Efficient and Scalable Production of Functional Single-Stranded DNA Nanostructures
AU  - Jinyi Hu
AU  - Wanqing Ding
AU  - Ning Jiang
AU  - Yujie Wang
AU  - Junjun Hou
AU  - Hongzhou Gu
AU  - Linjie Guo
AU  - Lihua Wang
AU  - Jiang Li
AU  - Jiaofang Huang
AU  - Jiangchao Qian
PY  - 2026
DA  - 2026/11/03
JO  - JACS Au
DO  - 10.1021/jacsau.6c01405
UR  - https://pubs.acs.org/jaaucr/article/doi/10.1021/jacsau.6c01405/5462646/Co-engineering-DNAzymes-and-Phagemid-Systems-for
AB  - DNA nanostructures have been widely explored for diverse applications, yet their scalable and cost-efficient production remains a major limitation. Phagemid-based biosynthesis of single-stranded DNA (ssDNA) provides a promising approach, but its efficiency is constrained by limited deoxyribozyme (DNAzyme) performance and suboptimal system design. Here, we develop an optimized bioproduction platform for ssDNA nanostructures by simultaneously engineering DNAzymes and phagemid-based production systems. Sequence-guided DNAzyme design identifies determinants for catalytic efficiency and pH adaptability, enabling highly efficient and robust in cis cleavage. The optimized DNAzymes achieve 100% self-cleavage within 30 min and expand the operational pH range from a narrow window around 7.2 to 6.6–7.8, thus enabling more reliable production of target ssDNA for structural folding. By combining optimization of phagemid constructs and helper phage/plasmid combinations, the resulting platform supports the biotechnological production of different nanostructures, including square and aptamer-functionalized triangle assemblies. With the p3024 phagemid and VCSM13 helper phage, production of functionalized triangular ssDNA nanostructures was successfully scaled to a 5 L bioreactor, yielding 151.0 mg/L phagemid ssDNA. Doxorubicin-loaded, aptamer AS1411-functionalized triangular nanostructures (DOX@DN-AS1411) enabled targeted and rapid intracellular drug delivery in breast cancer cells. This work establishes a scalable platform to produce programmable DNA nanostructures, facilitating their translation toward biomedical and nanomanufacturing applications.
SN  - 2691-3704
ER  -